AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies)

Recruitingn/aAges any - anyAllPitié-Salpêtrière Hospital
💬

In plain words

What the trial is, and whether it could suit you

Laminopathies and emerinopathies are complex group of rare disorders due to mutations in A-type lamins (LMNA) and Emerin (EMD) genes. Among them, disorders affecting skeletal and/or cardiac muscles are the most frequent clinical manifestations, with cardiac disease being a major cause of death. Remarkable progress has been made in the description of the clinical and genetic spectrum of these diseases since the 1990's. Until now, precise phenotype/genotype relations remain elusive. As for several other neuromuscular disorders, apart from symptomatic treatments, there is currently no specific treatment to prevent or slow down the progression of the disease. The OPALE registry is a multicentre web-based registry dedicated to laminopathy and emerinopathy French patients. OPALE has been approved by ethical and regulatory authorities. Its main inclusion criteria is the presence of a proven pat

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Presence of a proven pathogenic LMNA and/or EMD gene mutation * Regular followup in France. * Signed informed consent Exclusion Criteria: -Refusal to sign an informed consent.
💊

What it tests

  • Not listed
📍

Where

29 sites
Centre de référence maladies neuromusculaires,CHU d'Angers
Angers, France
CHU Strasbourg
Strasbourg, France
CHU Marseille
Marseille, France
CHU Caen
Caen, France
CHU Brest
Brest, France
CHU Nimes
Nîmes, France
CHU Bordeaux
Bordeaux, France
Centre de Référence de Pathologie NeuroMusculaire, CHU Toulouse
Toulouse, France

…and 21 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy